1. Inicio
  2. Proyectos y Estudios
  3. A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 4-ARM STUDY TO INVESTIGATE SYMPTOMS, FUNCTION, HEALTH-RELATED QUALITY OF LIFE AND SAFETY WITH REPEATED SUBCUTANEOUS ADMINISTRATION OF PONSEGROMAB VERSUS PLACEBO IN ADULT PARTICIPANTS WITH HEART FAILURE.

A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 4-ARM STUDY TO INVESTIGATE SYMPTOMS, FUNCTION, HEALTH-RELATED QUALITY OF LIFE AND SAFETY WITH REPEATED SUBCUTANEOUS ADMINISTRATION OF PONSEGROMAB VERSUS PLACEBO IN ADULT PARTICIPANTS WITH HEART FAILURE.

Datos básicos

ENSAYO CLÍNICO C3651011 2022-001809-50 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2023 Año de finalización: 2025

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

PFIZER INC.

Cita

Compartir